Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00127413
First received: August 3, 2005
Last updated: July 24, 2014
Last verified: July 2014

August 3, 2005
July 24, 2014
September 2004
September 2010   (final data collection date for primary outcome measure)
CAPS [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Pain - WHYMPI, MPQ (pre, post, 6-months)
  • Distress - BDI, STAI (pre, post, 6-months)
  • Disability - DQ, WHYMPI (pre, post, 6-months)
  • PTSD - CAPS, PCL (pre, post,6-months)
Complete list of historical versions of study NCT00127413 on ClinicalTrials.gov Archive Site
Not Provided
  • Anxiety Sensitivity Index-Pre,session 4 & 8, post,6-months
  • Coping Strategies Questionnaire-Pre,session 4 & 8, post,6-months
  • Fear and Avoidance - Pre, session 4 & 8, post, 6-months
Not Provided
Not Provided
 
Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
Integrated Treatment for Chronic Pain and PTSD

The purpose of this study is to examine the efficacy of an integrated treatment for Veterans with comorbid chronic pain and posttraumatic stress disorder. It is hypothesized that Veterans who receive the integrated treatment will report more positive outcomes than individuals who are assigned to treatment as usual, pain treatment, or PTSD treatment.

Chronic pain and post-traumatic stress disorder (PTSD) frequently co-occur and are associated with a significant level of affective distress, physical disability, and treatment resistance. However, no empirical studies have been conducted investigating the efficacy of a treatment tailored specifically for individuals with comorbid chronic pain and PTSD.

The primary objective of this study is to evaluate the efficacy of a cognitive-behavioral therapy (CBT) approach for comorbid chronic pain and PTSD. A secondary objective of this study is to examine potential mechanisms of action that might mediate treatment outcome. It is hypothesized that:

1.a) Participants receiving CBT-PTR (integrated cognitive-behavioral treatment for chronic pain and PTSD) will report significantly greater improvements on measures of pain, affective distress, and physical functioning from pre-treatment to post-treatment than participants in the CBT-PAIN (cognitive behavioral treatment for chronic pain), CBT-PTSD (cognitive behavioral treatment for PTSD), or TAU (treatment as usual) conditions;

1.b) CBT-PAIN, CBT-PTSD, and CBT-PTR will be more effective at promoting improved outcomes than TAU;

2) Participants receiving CBT-PTR will report decreased symptoms of PTSD from pre-treatment to post-treatment when compared to participants in the CBT-PAIN, CBT-PTSD and TAU conditions;

3) Participants receiving CBT-PTR will report greater maintenance of change, and greater improvements on measures of Pain, Affective Distress, Physical Functioning, and PTSD at 6 months following the completion of treatment than participants in the other three conditions;

4) As a secondary/exploratory hypothesis, the researchers will examine potential mechanisms of action in treatment.

It is hypothesized that changes in these potential mechanisms will mediate treatment outcome.

The proposed study is a four-treatment condition (CBT-PAIN, CBT-PTSD, CBT-PTR, and TAU) by three-evaluation period (pre-treatment, post-treatment, and 6-month follow-up) repeated measures factorial design with multiple dependent measures. Participants will be 136 patients with co-morbid chronic pain and PTSD receiving care in the VA Boston Healthcare System. Participants in the CBT-PAIN, CBT-PTSD, and CBT-PTR conditions will complete 11 weekly outpatient therapy sessions. A clinical psychologist with specialized training in providing both PTSD and chronic pain treatment protocols will conduct therapy in an individual format, 90 minutes in duration. Participants assigned to the TAU condition will not receive treatment beyond that provided by their primary care provider and other healthcare providers. The CBT-PAIN condition will follow an adaptation of a manualized treatment protocol used by Kerns and colleagues that emphasizes identifying and modifying maladaptive thoughts and behaviors related to the experience of chronic pain. Participants in the CBT-PTSD condition will receive a manualized treatment protocol developed by Keane and colleagues that includes several empirically supported techniques including cognitive restructuring, exposure therapy, and skills training. Participants in the CBT-PTR condition will receive an integrated treatment for comorbid pain and PTSD including components of the pain and PTSD treatments described above.

The proposed study will address the specific objectives of the National Pain Management Strategy by helping to assure that clinicians practicing in the VA healthcare system are adequately prepared to assess and manage chronic pain effectively, especially when comorbid with PTSD. Knowledge gained from the proposed study could potentially be utilized by psychologists and other healthcare providers across the VA system nationwide who are currently engaged in CBT treatment programs for chronic pain and PTSD. Given that CBT has been shown to be efficacious for pain and PTSD, but not for comorbid pain and PTSD, it is imperative that a new integrated treatment be evaluated that has the potential to address the unmet needs of this large population. Thus, this study will have important implications for the delivery of pain management services to veterans and others with chronic pain and PTSD.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Pain
  • Posttraumatic Stress Disorder
  • Behavioral: CBT-Pain (cognitive behavioral treatment for chronic pain)
    Pain treatment
  • Behavioral: CBT-PTR (integrated cognitive-behavioral treatment for chronic pain and PTSD)
    Integrated treatment
  • Behavioral: CBT-PTSD (cognitive behavioral treatment for PTSD)
    CPT
  • Behavioral: TAU (treatment as usual)
    Treatment as usual
  • Experimental: Arm 1
    Pain
    Intervention: Behavioral: CBT-Pain (cognitive behavioral treatment for chronic pain)
  • Experimental: Arm 2
    integrated treatment
    Intervention: Behavioral: CBT-PTR (integrated cognitive-behavioral treatment for chronic pain and PTSD)
  • Experimental: Arm 3
    CPT for PTSD
    Intervention: Behavioral: CBT-PTSD (cognitive behavioral treatment for PTSD)
  • Arm 4
    Treatment as Usual
    Intervention: Behavioral: TAU (treatment as usual)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
136
September 2010
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients will be eligible for participation if they have chronic pain, defined as constant pain of at least six months duration (International Association for the Study of Pain [IASP], 1994), with a neurologic or musculoskeletal etiology. Patients must also meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM-IV] diagnostic criteria for PTSD (American Psychiatric Association [APA], 1994).
  • Stability of pain and anxiety medications will be required for two months prior to study entry and during the active treatment/TAU phase.

Exclusion Criteria:

  • Patients with life threatening or acute physical illness (e.g., cancer).
  • Current alcohol or substance abuse or dependence. Veterans who have a history of alcohol or drug dependence but who have not had problematic use in the last six months will be included in the study.
  • Current psychosis or suicidal ideation.
  • Individuals seeking pain treatment such as surgical interventions will be excluded.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00127413
D3322-R
No
Department of Veterans Affairs
Department of Veterans Affairs
Not Provided
Principal Investigator: John Otis, BS BA PhD VA Boston Health Care System, Jamaica Plain
Department of Veterans Affairs
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP